Use of fertility treatments in BRCA1/2 mutation carriers and risk for ovarian and breast cancer: a systematic review

PURPOSE: Mutations in the genes BRCA1 and BRCA2 represent a significant risk factor for ovarian and breast cancer. With increasing number and success rates, fertility protection and treatment are gaining importance also for BRCA1/2 mutation carriers. However, the effect on primary cancer risk and ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Huber, D., Seitz, S., Kast, K., Emons, G., Ortmann, O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Gynecologic Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447664/
https://www.ncbi.nlm.nih.gov/pubmed/32719921
http://dx.doi.org/10.1007/s00404-020-05690-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447664/
https://www.ncbi.nlm.nih.gov/pubmed/32719921
http://dx.doi.org/10.1007/s00404-020-05690-4

Ejemplares similares